Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Lymphoma, Large B-Cell, Diffuse 53Lymphoma, Non-Hodgkin 33Leukemia 33Burkitt Lymphoma 33Lymphoma, Mantle-Cell 20Lymphoma, Follicular 19Recurrence 13Lymphoma, B-Cell 13Hodgkin Disease 13Neoplasms 11Lymphoma, Large-Cell, Anaplastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Sarcoma 9Neuroblastoma 8Multiple Myeloma 8Medulloblastoma 8Lymphoma, T-Cell, Peripheral 8Lymphoma, T-Cell 7Central Nervous System Neoplasms 7Rhabdomyosarcoma 6Leukemia, Biphenotypic, Acute 6Lymphoma, B-Cell, Marginal Zone 5Wilms Tumor 4Waldenstrom Macroglobulinemia 4Sarcoma, Ewing 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Temozolomide 7Magnetic Resonance Spectroscopy 7X-Rays 5Phantoms, Imaging 5Bevacizumab 5Specimen Handling 4Nuclear Medicine Department, Hospital 4Carboplatin 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2Vemurafenib 2Lapatinib 2LY3023414 2Everolimus 2Etoposide 2Erlotinib Hydrochloride 2veliparib 1pomalidomide 1poly ICLC 1picropodophyllin 1marizomib 1imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ependymoma × Vincristine × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡